who are these boneheads at cnbc to tell me who impresses or who doesn't? and if what they say take down a stock, i might as well buy if i see otherwise.
the expenses you are talking about above excludes other compensations...they will be out of cash. you will revisit this post later this year.
people who really understand biotechs and or celg, should not get too excited about one day move...good things continue to come for the company and its a long term hold. but to follow the developments of this company is pretty exciting.
if you take the splits into consideration, well, it would be well above 600 right now. so its gonna split again when it goes 160 sometime next year.
they say gild's manufacturing cost shows mark up of 279,000 percents...but they fail to report the acquisition cost and development to bring the drug to market...those so call reporters quoted from esrx...the liberal media is just plain deceptive and dishonest.
everyone who wants it already own it. all of a sudden the watch is an issue for the stock...its not even out yet. so only negative stuff can move it down...nothing good will move it up...